News
Innovative Medicines based on
ImmunoModulatory Biologics
-
Media Room
-
News
IMBiologics Corp. announced a License Agreement with Huadong Medicines
-
- Date
- 2024-08-16 12:03:32
-
- View
- 485
For more information, please visit : IMBiologics News (full article available in Korean)
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea